A detailed history of Northern Trust Corp transactions in Novartis Ag stock. As of the latest transaction made, Northern Trust Corp holds 1,732,729 shares of NVS stock, worth $181 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,732,729
Previous 2,059,243 15.86%
Holding current value
$181 Million
Previous $219 Million 9.09%
% of portfolio
0.03%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$106.13 - $120.89 $34.7 Million - $39.5 Million
-326,514 Reduced 15.86%
1,732,729 $199 Million
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $8.48 Million - $9.84 Million
-91,653 Reduced 4.26%
2,059,243 $219 Million
Q1 2024

May 14, 2024

BUY
$95.27 - $108.47 $1.02 Million - $1.16 Million
10,724 Added 0.5%
2,150,896 $208 Million
Q4 2023

Feb 13, 2024

SELL
$92.27 - $101.54 $2.51 Million - $2.76 Million
-27,185 Reduced 1.25%
2,140,172 $216 Million
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $5.94 Million - $6.6 Million
-62,739 Reduced 2.81%
2,167,357 $221 Million
Q2 2023

Aug 11, 2023

SELL
$92.52 - $104.91 $28.4 Million - $32.2 Million
-306,454 Reduced 12.08%
2,230,096 $225 Million
Q1 2023

May 15, 2023

BUY
$80.03 - $92.81 $224,884 - $260,796
2,810 Added 0.11%
2,536,550 $233 Million
Q4 2022

Feb 13, 2023

SELL
$75.55 - $92.52 $7.06 Million - $8.64 Million
-93,383 Reduced 3.55%
2,533,740 $230 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $10.5 Million - $12.3 Million
-140,671 Reduced 5.08%
2,627,123 $200 Million
Q2 2022

Aug 12, 2022

SELL
$80.52 - $93.75 $6.05 Million - $7.05 Million
-75,194 Reduced 2.64%
2,767,794 $234 Million
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $21.3 Million - $24 Million
-265,285 Reduced 8.53%
2,842,988 $249 Million
Q4 2021

Feb 08, 2022

SELL
$79.7 - $88.13 $11.7 Million - $12.9 Million
-146,325 Reduced 4.5%
3,108,273 $272 Million
Q3 2021

Nov 15, 2021

SELL
$81.78 - $95.14 $25.5 Million - $29.7 Million
-312,235 Reduced 8.75%
3,254,598 $266 Million
Q2 2021

Aug 13, 2021

SELL
$85.24 - $94.15 $22.1 Million - $24.5 Million
-259,720 Reduced 6.79%
3,566,833 $325 Million
Q1 2021

May 12, 2021

SELL
$83.5 - $98.47 $246,158 - $290,289
-2,948 Reduced 0.08%
3,826,553 $327 Million
Q4 2020

Feb 11, 2021

SELL
$78.07 - $94.43 $4.09 Million - $4.95 Million
-52,380 Reduced 1.35%
3,829,501 $362 Million
Q3 2020

Nov 16, 2020

BUY
$82.14 - $91.0 $10 Million - $11.1 Million
121,778 Added 3.24%
3,881,881 $338 Million
Q2 2020

Aug 14, 2020

BUY
$80.93 - $91.1 $12.8 Million - $14.4 Million
158,037 Added 4.39%
3,760,103 $328 Million
Q1 2020

May 14, 2020

SELL
$70.67 - $99.01 $28.2 Million - $39.5 Million
-399,006 Reduced 9.97%
3,602,066 $297 Million
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $4.21 Million - $4.76 Million
49,931 Added 1.26%
4,001,072 $379 Million
Q3 2019

Nov 13, 2019

SELL
$85.54 - $94.26 $1.02 Million - $1.12 Million
-11,886 Reduced 0.3%
3,951,141 $343 Million
Q2 2019

Aug 13, 2019

BUY
$75.4 - $92.8 $3.88 Million - $4.78 Million
51,518 Added 1.32%
3,963,027 $362 Million
Q1 2019

May 13, 2019

SELL
$75.32 - $86.15 $10.1 Million - $11.6 Million
-134,229 Reduced 3.32%
3,911,509 $376 Million
Q4 2018

Feb 12, 2019

SELL
$73.66 - $82.02 $10.1 Million - $11.3 Million
-137,303 Reduced 3.28%
4,045,738 $347 Million
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $6.09 Million - $7.05 Million
91,024 Added 2.22%
4,183,041 $360 Million
Q2 2018

Sep 18, 2018

SELL
$64.91 - $73.36 $12.8 Million - $14.4 Million
-196,752 Reduced 4.59%
4,092,017 $309 Million
Q2 2018

Aug 14, 2018

BUY
$64.91 - $73.36 $12.9 Million - $14.6 Million
199,198 Added 4.87%
4,288,769 $324 Million
Q1 2018

May 09, 2018

BUY
$70.39 - $84.15 $6.34 Million - $7.57 Million
90,010 Added 2.25%
4,089,571 $331 Million
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $2.6 Million - $2.79 Million
35,897 Added 0.91%
3,999,561 $336 Million
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $294 Million - $306 Million
3,963,664
3,963,664 $340 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.